Daytona Beach, Florida Clinical Trials

A listing of Daytona Beach, Florida clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 7 clinical trials
A Study of LY3522348 in Healthy Participants

The main purpose of this study in healthy participants is to learn more about the safety of LY3522348 and any side effects that might be associated with it. Blood tests will be performed to check how much LY3522348 gets into the bloodstream and how long it takes the body to …

Covance Clinical Research Inc
 (2.9 away) Contact site
  • 12 May, 2021
  • 1 location
A Study of LY3484356 in Healthy Female Participants

The main purpose of this study is to evaluate the amount of LY3484356 is found in the blood stream and how long the body takes to get rid of it when given with and without food, in healthy females participants of non-childbearing potential. The study will also evaluate the tolerability …

Covance Clinical Research Inc
 (2.9 away) Contact site
  • 14 May, 2021
  • +1 other locations
Assessment of Safety Tolerability Immunogenicity and Pharmacokinetics of AZD3427

This first-time-in-human (FTIH) study will be conducted to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of single doses of AZD3427 in healthy volunteers and multiple doses of AZD3427 in patients with heart failure (HF).

heart failure
b-type natriuretic peptide
body mass index
natriuretic peptide
medical therapy
Research Site
 (76.8 away) Contact site
  • 02 Jun, 2021
  • +12 other locations
A Study of LY3372993 in Participants With Alzheimer's Disease (AD)

The main purpose of this study is to evaluate the safety and tolerability of LY3372993 in participants with AD. The study will also investigate how much LY3372993 gets into the bloodstream and will test the effects of LY3372993. Participation could last up to about 54 weeks and may include up …

cognitive impairment
mini-mental state examination
mental state examination
mild cognitive impairment
Progressive Medical Research
 (7.0 away) Contact site
  • 30 Apr, 2021
  • +12 other locations
A Study to Evaluate the Safety Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)

The purpose of this study is to evaluate the safety and tolerability of TAK-079 in comparison with matching placebo, administered once every 3 weeks over a 12-week dosing period in participants with active SLE who are receiving stable background therapy for SLE.

Millennium Research
 (6.4 away) Contact site
  • 27 Jan, 2021
  • +16 other locations
Safety Tolerability and Pharmacokinetic Study of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis

TRK-250 is a nucleic acid medicine that inhibits the progression of pulmonary fibrosis by selectively suppressing the expression of transforming growth factor-beta 1 (TGF-1) protein, at the gene expression level. This study is a double-blind, randomized, placebo-controlled Phase I study. The primary objective of the study is to assess the …

idiopathic pulmonary fibrosis
diffusion capacity of the lung for carbon monoxide
Advanced Pulmonary & Sleep Research Institute of Florida
 (2.9 away) Contact site
  • 23 May, 2021
  • +12 other locations
A Single-blind Placebo-controlled Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870

Despite availability of several antiepileptic drugs (AEDs), in one-third of patients, epilepsy remains uncontrolled with AEDs. There is a need to develop new approaches to improve the existing medications to relieve patients' epilepsy, and OPC-214870 is being studied for this purpose.

For additional information regarding sites, contact 844-687-8522
 (5.9 away) Contact site
  • 24 May, 2021
  • 1 location